Overview

Evaluation of Varenicline Safety, Tolerability, Pharmacokinetics and Pro-Cognitive Effects in Healthy Elderly Non-Smoking Subjects

Status:
Completed

Trial end date:
2008-06-01

Target enrollment:

Participant gender:

Summary

1. Characterize the tolerability and safety of repeated doses of varenicline in healthy non-smoking elderly subjects. 2. Describe the steady state pharmacokinetics of varenicline in healthy non-smoking elderly subjects. 3. Evaluate the potential effects of repeat doses of varenicline on cognition in healtly non-smoking elderly subjects.

Phase:

Phase 1

Details

Lead Sponsor:

Pfizer

Treatments:

Varenicline